Tremfya® MOA Video

Tremfya® MOA Video

In Patients with Moderate to Severe Plaque Psoriasis
Introducing Tremfya®, the first fully human antibody to selectively bind to the p19 subunit of IL-23 and inhibit its interaction with the IL-23 receptor.

 

Sponsored content.

 

Some of Our Sponsors